| Lipidomics in Understanding Pathophysiology and Pharmacologic Effects in Inflammatory Diseases: Considerations for Drug Development K Ahluwalia, B Ebright, K Chow, P Dave, A Mead, R Poblete, SG Louie, ... Metabolites 12 (4), 333, 2022 | 30 | 2022 |
| The Future of CMC Regulatory Submissions: Streamlining Activities Using Structured Content and Data Management K Ahluwalia, MJ Abernathy, J Beierle, NS Cauchon, D Cronin, S Gaiki, ... Journal of Pharmaceutical Sciences, 2021 | 22 | 2021 |
| NAP1051, a Lipoxin A4 Biomimetic Analogue, Demonstrates Antitumor Activity Against the Tumor MicroenvironmentTargeting the Inflammatory TME Shows Antitumor Effect T Dong, P Dave, EJ Yoo, B Ebright, K Ahluwalia, E Zhou, I Asante, ... Molecular Cancer Therapeutics 20 (12), 2384-2397, 2021 | 15 | 2021 |
| Design, synthesis and evaluation of antiproliferative activity of melanoma-targeted histone deacetylase inhibitors I Raji, K Ahluwalia, AK Oyelere Bioorganic & medicinal chemistry letters 27 (4), 744-749, 2017 | 6 | 2017 |
| Mechanistic investigation of NAP1051, a lipoxin A4 biomimetic, in treating colorectal cancer T Dong, P Dave, B Ebright, K Ahluwalia, E Zhou, I Asante, M Salimova, ... Cancer Research 81 (13_Supplement), 1436-1436, 2021 | | 2021 |
| Oral administration of novel compound targeting triple negative breast cancer (TNBC) through the inhibition of SERCA2 T Lin, J Yoo, P Dave, A Mead, K Ahluwalia, T Dong, E Zhou, H Pei, ... Cancer Research 80 (16_Supplement), 4172-4172, 2020 | | 2020 |
| Histological and molecular findings in the Retinal Pigment Epithelium after Selective Retinal Therapy with Real Time Feedback Technology JC Martinez, X Wu, K Ahluwalia, E Zhou, Z Du, J Hilser, M Humayun, ... Investigative Ophthalmology & Visual Science 61 (7), 1353-1353, 2020 | | 2020 |
